Equine hEGF antibody and antigen (recombinant protein)

Diagnostic anti-Equine hEGF antibodies pairs and antigen for animal health (animal Equine/Horse lung cancer, anal cancers, glioblastoma and epithelian tumors of the head and neck) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Equine disease testing products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-EQU-hEGF-Ag01Equine hEGF$3090.00
GMP-EQU-hEGF-Ab01Anti-Equine hEGF mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-hEGF-Ab02Anti-Equine hEGF mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-hEGF-Ab03Anti-Equine hEGF human monoclonal antibody (mAb)$3090.00
GMP-EQU-hEGF-Ab04Anti-Equine hEGF human monoclonal antibody (mAb)$3090.00

Size： 1mg | 10mg | 100mg



Product Description

Cat No. GMP-EQU-hEGF-Ag01
Product NameEquine hEGF
Target/BiomarkerEquine hEGF
Expression platformE.coli
IsotypesRecombinant Antigen
Bioactivity validationAnti-Equine hEGF antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in hEGF level test of animal Equine/Horse with lung cancer, anal cancers, glioblastoma and epithelian tumors of the head and neck.
TagHis
Reconized/Reactive SpecicsEquine hEGF
Product descriptionRecombinant Equine hEGF protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-hEGF-Ab01,GMP-EQU-hEGF-Ab02
Target/BiomarkerEquine hEGF
Product NameAnti-Equine hEGF mouse monoclonal antibody (mAb)
Expression platformCHO
Isotypes Mouse IgG
Bioactivity validationRecombinant Equine hEGF antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine hEGF antibodies in Equine hEGF level test of animal Equine/Horse with lung cancer, anal cancers, glioblastoma and epithelian tumors of the head and neck.
Product descriptionAnti-Equine hEGF mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine hEGF antibodies.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-hEGF-Ab03,GMP-EQU-hEGF-Ab04
Target/BiomarkerEquine hEGF
Product NameAnti-Equine hEGF human monoclonal antibody (mAb)
Expression platformCHO
IsotypesHuman lgG1
Bioactivity validationRecombinant Equine hEGF antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine hEGF antibodies in Equine hEGF level test of animal Equine/Horse with lung cancer, anal cancers, glioblastoma and epithelian tumors of the head and neck.
Product descriptionAnti-Equine hEGF mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker Information


    Human Epidermal Growth Factor (hEGF) is a protein with profound implications in cell biology and tissue regeneration. Although its origin is human, EGF-related molecules and signaling pathways have also been identified in horses (equines), albeit with structural differences.

    EGF is a member of the epidermal growth factor family, a group of proteins known for their pivotal roles in regulating cell growth, proliferation, and tissue repair. The principal receptor for EGF is the Epidermal Growth Factor Receptor (EGFR), which is present on the surface of various cell types. Upon binding to EGFR, EGF initiates a cascade of intracellular events that stimulate cell division, tissue repair, and the maintenance of healthy epithelial tissues.

    In horses, EGF-like molecules and their associated signaling pathways exhibit functional similarities to their human counterparts. While the specific structure of EGF in horses may not be identical to that in humans, the fundamental principles of EGF-mediated cellular responses are conserved. This implies that EGF pathways play essential roles in equine physiology, contributing to tissue homeostasis, repair, and regeneration.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.